Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. TAMOXIFEN TABLET 20 MG [SIN07094P]

TAMOXIFEN TABLET 20 MG [SIN07094P]

Active ingredients: TAMOXIFEN TABLET 20 MG

Last updated 26 October 2025

Product Info

TAMOXIFEN TABLET 20 MG

[SIN07094P]

Product information

Active Ingredient and Strength

TAMOXIFEN CITRATE EQV TAMOXIFEN - 20 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

TEVA PHARMACEUTICAL INDUSTRIES LTD - ISRAEL

Registration Number

SIN07094P

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

L02BA01

4.1. Therapeutic indications
Tamoxifen is used for the treatment of breast cancer.

4.2. Posology and method of administration
For oral administration.

Adults (including elderly)
The dosage range is 20 to 40 mg daily, given either in divided doses twice daily or as a single dose once daily.

Use in children
The use of Tamoxifen is not recommended in children, as safety and efficacy have not been established (see Pharmacodynamic and Pharmacokinetics properties – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

4.3. Contraindications
Tamoxifen must not be given during pregnancy. Pre-menopausal patients must be carefully examined before treatment for breast cancer or infertility to exclude the possibility of pregnancy (see section 4.6. – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
Tamoxifen should not be given to patients who have experienced hypersensitivity to the product or any of its ingredients.